Guangxin Li

1PUBLICATIONS
0CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 15, 2023
Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre.

Guangxin Li, Ying Zhao, Keren Li

Pageof 1

Frequent Collaborators